CXCL12 and Miyoshi myopathy: Interestingly, enhanced CXCL12-CXCR4 signaling in the BM was found to restrict MM cells from leaving the primary BM and re-entering the blood circulation, so increased CXCR4 expression in BM MM plasma cells led to reduced tumor dissemination and better prognosis 118-120.